• linkedin
  • Increase Font
  • Sharebar

    A new class of biologics in the PCSK9 Inhibitors likely will be approved for treating high cholesterol. How are you preparing?

    41%
    Conducting budgetary impact analyses
    26%
    Conducting pre-approval clinical review thru P&T
    7%
    Developing pre-approval prior authorization criteria
    18%
    All of the above
    9%
    Nothing of yet, waiting til FDA approval